Which factors predict bowel complications in patients with recurrent epithelial ovarian cancer being treated with bevacizumab?

D. L. Richardson, F. J. Backes, J. D. Hurt, L. G. Seamon, L. J. Copeland, J. M. Fowler, D. E. Cohn, D. M. O'Malley

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Fingerprint Dive into the research topics of 'Which factors predict bowel complications in patients with recurrent epithelial ovarian cancer being treated with bevacizumab?'. Together they form a unique fingerprint.

Medicine & Life Sciences